Chapter 20. Infective Endocarditis

  1. Mark J. D. Griffiths MRCP, PhD, EDICM, BDICM Consultant,
  2. Jeremy J. Cordingley MRCP, FRCA, EDICM Consultant and
  3. Susanna Price MRCP, PhD, EDICM, FESC Consultant
  1. David Hunter MD, MBBS, FRCA Consultant Anaesthetist Intensivist1 and
  2. John Pepper M.Chir, FRCS Professor of Cardiothoracic Surgery2

Published Online: 9 JUL 2010

DOI: 10.1002/9781444314502.ch20

Cardiovascular Critical Care

Cardiovascular Critical Care

How to Cite

Hunter, D. and Pepper, J. (2010) Infective Endocarditis, in Cardiovascular Critical Care (eds M. J. D. Griffiths, J. J. Cordingley and S. Price), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444314502.ch20

Editor Information

  1. Royal Brompton & Harefield NHS Foundation Trust London, UK

Author Information

  1. 1

    Anaesthetic Department, Royal Brompton & Harefield NHS Foundation Trust, London, UK

  2. 2

    Department of Surgery, Royal Brompton & Harefield NHS Foundation Trust, London, UK

Publication History

  1. Published Online: 9 JUL 2010
  2. Published Print: 30 JUL 2010

ISBN Information

Print ISBN: 9781405148573

Online ISBN: 9781444314502



  • Congenital heart disease (CHD) is also a risk factor;
  • Excellence (NICE) in England recommended that at-risk patients;
  • spatial resolution than TTE and can depict structures;
  • Fungal endocarditis is also principally seen in IVDU;
  • suspicion of an aortic root abscess or in PVE;
  • Two weeks later, a combination of TTE and TOE;
  • Echocardiographic evidence of infective endocarditis;
  • diabetes mellitus, human immunodefiency virus (HIV)


This chapter contains sections titled:

  • Introduction

  • Definition and incidence

  • Pathogenesis

  • Susceptible patients

  • Prevention

  • Diagnosis

  • Causative organisms (Table 20.4)

  • Complications

  • Management

  • Outcome and prognosis

  • Summary

  • Acknowledgement

  • References